Body And Mind Inc
General ticker "BMMJ" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.6M
Body And Mind Inc does not follow the US Stock Market performance with the rate: -48.8%.
Estimated limits based on current volatility of 29.3%: low 0.01$, high 0.02$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-07-31 to 2025-07-30
- 2023-07-31 to 2024-07-30 estimated range: [0.04$, 0.09$]
- 2024-07-30 to 2025-07-30 estimated range: [0.04$, 0.09$]
Financial Metrics affecting the BMMJ estimates:
- Negative: Non-GAAP EPS, $ of -0.16 <= 0.10
- Negative: Operating profit margin, % of -25.16 <= 1.03
- Negative: Operating cash flow per share per price, % of -31.96 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -5.82 <= 1.31
- Positive: Inventory ratio change, % of -5.38 <= -1.03
- Positive: Industry inventory ratio change (median), % of -2.38 <= -0.39
Short-term BMMJ quotes
Long-term BMMJ plot with estimates
Financial data
| YTD | 2021-07-31 | 2022-07-31 | 2023-07-31 |
|---|---|---|---|
| Operating Revenue | $25.70MM | $23.37MM | $22.82MM |
| Operating Expenses | $25.11MM | $27.88MM | $30.49MM |
| Operating Income | $0.59MM | $-4.51MM | $-7.67MM |
| Non-Operating Income | $-0.40MM | $-22.13MM | $-10.48MM |
| Interest Expense | $0.05MM | $1.37MM | $1.72MM |
| R&D Expense | $0.28MM | $0.67MM | $0.84MM |
| Income(Loss) | $0.19MM | $-26.64MM | $-18.15MM |
| Taxes | $2.17MM | $1.77MM | $2.17MM |
| Other Income(Loss) | $0.00MM | $0.19MM | $-0.24MM |
| Profit(Loss) | $-1.98MM | $-28.23MM | $-20.57MM |
| Stockholders Equity | $34.35MM | $9.63MM | $-10.27MM |
| Inventory | $2.94MM | $3.88MM | $2.31MM |
| Assets | $48.13MM | $31.03MM | $21.21MM |
| Operating Cash Flow | $0.29MM | $-3.44MM | $-3.83MM |
| Capital expenditure | $0.40MM | $0.83MM | $0.99MM |
| Investing Cash Flow | $-0.83MM | $-2.15MM | $-0.07MM |
| Financing Cash Flow | $6.17MM | $-0.03MM | $3.52MM |
| Earnings Per Share* | $-0.02 | $-0.25 | $-0.16 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.